Alison Lawton
2020 - Kaleido Biosciences
In 2020, Alison Lawton earned a total compensation of $1.1M as Former President and Chief Executive Officer former principal executive officer at Kaleido Biosciences, a 61% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $257,500 |
|---|---|
| Option Awards | $351,745 |
| Salary | $515,000 |
| Other | $11,323 |
| Total | $1,135,568 |
Lawton received $515K in salary, accounting for 45% of the total pay in 2020.
Lawton also received $257.5K in non-equity incentive plan, $351.7K in option awards and $11.3K in other compensation.
Rankings
In 2020, Alison Lawton's compensation ranked 8,080th out of 13,090 executives tracked by ExecPay. In other words, Lawton earned more than 38.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,080 out of 13,090 | 38th |
Division Manufacturing | 3,430 out of 5,621 | 39th |
Major group Chemicals And Allied Products | 1,385 out of 2,254 | 39th |
Industry group Drugs | 1,206 out of 1,954 | 38th |
Industry Biological Products, Except Diagnostic Substances | 284 out of 411 | 31st |
Source: SEC filing on May 5, 2021.
Lawton's colleagues
We found three more compensation records of executives who worked with Alison Lawton at Kaleido Biosciences in 2020.